Tg Therapeutics Inc (TGTX)

Cost of Revenue

$41.19M

Quarterly · Period ending: · USD

TGTX logo

TGTX Cost of Revenue

Latest reported$41.19M
TGTX Quarterly Cost of Revenue ($0.00 → $41.19M)
High-resolution chart · PNG

TGTX cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
41,194,000
33,510,000
38,142,000
28,155,000
18,938,000
15,541,000
15,399,000
9,341,000
8,304,000
5,523,000
7,946,000
3,509,000
1,911,000
857,000
3,000
2,000
23,000
237,000
210,000
292,000
148,000
139,000
106,000
0
0
0
169,055,000
0
0
0
0
0
0
0
0
0
0
0
78,969,128,000
0
0
0
0
0
0
0
55,721,092
0
0
0
22,965,989
0
0
0
26,895,099
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,257
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.